Acadian Asset Management LLC Purchases Shares of 10,495 Simulations Plus, Inc. (SLP)  Anthony Miller | Aug 17th, 2018
Acadian Asset Management LLC purchased a new stake in Simulations Plus, Inc. (NASDAQ:SLP) in the second quarter, according to its most recent filing with the SEC. The fund purchased 10,495 shares of the technology company's stock, valued at approximately $233,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Citigroup Inc. increased its holdings in shares of Simulations Plus by 1,154.8% in the 1st quarter. Citigroup Inc. now owns 11,670 shares of the technology company's stock valued at $172,000 after acquiring an additional 10,740 shares during the last quarter. Bank of Montreal Can bought a new position in Simulations Plus during the 2nd quarter worth $186,000. TIAA FSB bought a new position in Simulations Plus during the 2nd quarter worth $225,000. Wells Fargo & Company MN grew its stake in Simulations Plus by 234.1% during the 4th quarter. Wells Fargo & Company MN now owns 17,028 shares of the technology company's stock worth $275,000 after buying an additional 11,931 shares during the last quarter. Finally, Deutsche Bank AG grew its stake in Simulations Plus by 27.4% during the 4th quarter. Deutsche Bank AG now owns 24,583 shares of the technology company's stock worth $394,000 after buying an additional 5,282 shares during the last quarter. Institutional investors and hedge funds own 34.28% of the company's stock. Get Simulations Plus alerts:
In related news, Chairman Walter S. Woltosz sold 18,500 shares of the company's stock in a transaction on Tuesday, May 29th. The stock was sold at an average price of $19.27, for a total transaction of $356,495.00. Following the completion of the transaction, the chairman now directly owns 5,454,408 shares in the company, valued at approximately $105,106,442.16. The sale was disclosed in a document filed with the SEC, which is available through this link . 33.45% of the stock is owned by corporate insiders.
SLP has been the subject of a number of recent research reports. BidaskClub downgraded Simulations Plus from a "buy" rating to a "hold" rating in a research note on Tuesday, May 1st. Zacks Investment Research upgraded Simulations Plus from a "hold" rating to a "buy" rating and set a $20.00 price objective for the company in a research note on Saturday, July 21st. Finally, ValuEngine upgraded Simulations Plus from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 14th.
Shares of SLP opened at $19.05 on Friday. The firm has a market cap of $321.25 million, a P/E ratio of 56.03 and a beta of -0.85. Simulations Plus, Inc. has a 12 month low of $13.98 and a 12 month high of $23.95.
Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings data on Tuesday, July 10th. The technology company reported $0.13 EPS for the quarter, topping the Zacks' consensus estimate of $0.12 by $0.01. The firm had revenue of $8.55 million during the quarter, compared to the consensus estimate of $7.86 million. Simulations Plus had a return on equity of 25.65% and a net margin of 29.88%. analysts anticipate that Simulations Plus, Inc. will post 0.4 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 2nd. Investors of record on Thursday, July 26th were paid a dividend of $0.06 per share. The ex-dividend date was Wednesday, July 25th. This represents a $0.24 dividend on an annualized basis and a yield of 1.26%. Simulations Plus's payout ratio is currently 70.59%.
Simulations Plus Profile
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Further Reading: Stock Symbols Definition, Examples, Lookup
Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP). Simulations Plus Simulations Plu